Aventis ag business
Executive Summary
Aventis intends to divest its animal nutrition business, not its animal health business Merial (1"The Pink Sheet" Aug. 7, p. 19). Sales for the second quarter in the animal nutrition business were €142 mil. ($128.9 mil.), flat compared to the second quarter of 1999
You may also be interested in...
Aventis Decision On Ag Business Expected Within 18 Months
Aventis expects to make a decision on carrying forward with its agricultural business component in 2001, Investor Relations Director Arvind Sood said during a July 28 conference call.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials